Syndax Pharmaceuticals, Inc. (SNDX)
24.25
-0.19
(-0.78%)
USD |
NASDAQ |
Apr 13, 16:00
24.25
0.00 (0.00%)
After-Hours: 20:00
Syndax Pharmaceuticals Cash from Investing (TTM) : 290.04M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Cogent Biosciences, Inc. | -399.53M |
| Vera Therapeutics, Inc. | 194.29M |
| Biogen, Inc. | -1.371B |
| Johnson & Johnson | -23.59B |
| Tango Therapeutics, Inc. | -40.86M |